The 5-Second Trick For GW3965 hydrochloride
All enrolled clients who been given not less than a single dose of zosuquidar or placebo during induction have been monitored with the occurrence of adverse activities (439 sufferers, 219 on zosuquidar and 210 on placebo). The commonest adverse events were being associated with the period of prolonged and substantial myelosuppression as is anticipa